ETF Holdings Breakdown of ACLX

Stock NameArcellx Inc
TickerACLX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03940C1009

News associated with ACLX

Dimensional Fund Advisors LP Acquires 186,013 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Dimensional Fund Advisors LP lifted its holdings in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 156.2% in the fourth quarter, Holdings Channel reports. The fund owned 305,088 shares of the company’s stock after purchasing an additional 186,013 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Arcellx were worth $23,400,000 at the end of […] - 2025-05-07 08:22:53
Mariner LLC Increases Stake in Arcellx, Inc. (NASDAQ:ACLX)
Mariner LLC grew its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 37.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,980 shares of the company’s stock after purchasing an additional 1,915 shares during the period. Mariner LLC’s holdings […] - 2025-05-02 08:08:50
Invesco Ltd. Boosts Stake in Arcellx, Inc. (NASDAQ:ACLX)
Invesco Ltd. boosted its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 15.7% in the 4th quarter, Holdings Channel reports. The firm owned 26,550 shares of the company’s stock after purchasing an additional 3,610 shares during the period. Invesco Ltd.’s holdings in Arcellx were worth $2,036,000 at the end of the most recent quarter. […] - 2025-04-30 07:44:58
Renaissance Technologies LLC Takes $3.77 Million Position in Arcellx, Inc. (NASDAQ:ACLX)
Renaissance Technologies LLC bought a new stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 49,100 shares of the company’s stock, valued at approximately $3,765,000. Renaissance Technologies LLC owned approximately 0.09% of Arcellx at […] - 2025-04-23 08:27:02
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Legal & General Group Plc
Legal & General Group Plc reduced its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 3.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 43,033 shares of the company’s stock after selling 1,402 shares during the period. Legal & General Group Plc’s holdings in Arcellx were worth $3,300,000 as of […] - 2025-04-23 08:26:58
Wellington Management Group LLP Sells 1,275 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Wellington Management Group LLP reduced its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 6.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,693 shares of the company’s stock after selling 1,275 shares during the period. Wellington Management […] - 2025-04-14 07:44:59
Trexquant Investment LP Purchases Shares of 7,237 Arcellx, Inc. (NASDAQ:ACLX)
Trexquant Investment LP acquired a new position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 7,237 shares of the company’s stock, valued at approximately $555,000. Other hedge funds have also made changes to their positions in the […] - 2025-04-13 09:00:57
Pictet Asset Management Holding SA Purchases 1,426 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Pictet Asset Management Holding SA grew its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 40.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,945 shares of the company’s stock after buying an additional 1,426 shares during the period. Pictet Asset Management […] - 2025-04-10 08:37:03
Arcellx (NASDAQ:ACLX) Stock Price Down 6.8% After Insider Selling
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) traded down 6.8% during trading on Wednesday following insider selling activity. The company traded as low as $49.55 and last traded at $49.95. 248,582 shares changed hands during trading, a decline of 63% from the average session volume of 668,721 shares. The stock had previously closed at $53.60. […] - 2025-04-10 05:40:50
Arcellx, Inc. (NASDAQ:ACLX) Stock Holdings Lessened by Corebridge Financial Inc.
Corebridge Financial Inc. cut its stake in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 7.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,430 shares of the company’s stock after selling 1,617 shares during the quarter. Corebridge […] - 2025-04-03 07:34:47
Thrivent Financial for Lutherans Has $5.33 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX)
Thrivent Financial for Lutherans increased its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 44.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 69,461 shares of the company’s stock after purchasing an additional 21,221 shares during the period. Thrivent Financial for Lutherans’ holdings in Arcellx were worth $5,327,000 as […] - 2025-03-25 09:08:51
Victory Capital Management Inc. Sells 43,236 Shares of Arcellx, Inc. (NASDAQ:ACLX)
Victory Capital Management Inc. trimmed its stake in Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 184,183 shares of the company’s stock after selling 43,236 shares during the period. Victory Capital Management Inc.’s holdings in Arcellx were worth $14,125,000 at the end of the most […] - 2025-03-13 08:32:53
Analysts Set Arcellx, Inc. (NASDAQ:ACLX) PT at $105.93
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the fifteen ratings firms that are currently covering the company, MarketBeat.com reports. Thirteen equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month target […] - 2025-02-27 06:22:50
Contrasting Arcellx (NASDAQ:ACLX) and C4 Therapeutics (NASDAQ:CCCC)
C4 Therapeutics (NASDAQ:CCCC – Get Free Report) and Arcellx (NASDAQ:ACLX – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Volatility & Risk C4 Therapeutics has a beta of […] - 2025-02-05 06:06:45

ACLX institutional holdings

The following institutional investment holdings of ACLX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 23,243USD 1,307,651
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 7,727USD 434,721 5.9%
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 43,713USD 2,459,293
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 26,168USD 1,472,212
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 26,168USD 1,472,212 5.9%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 84USD 4,726
Total =127,103 USD 7,150,815
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.